These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33963573)

  • 1. Effect of CES1 genetic variation on enalapril steady-state pharmacokinetics and pharmacodynamics in healthy subjects.
    Her LH; Wang X; Shi J; Choi HJ; Jung SM; Smith LS; Wu AH; Bleske BE; Zhu HJ
    Br J Clin Pharmacol; 2021 Dec; 87(12):4691-4700. PubMed ID: 33963573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of carboxylesterase 1 c.428G > A single nucleotide variation on the pharmacokinetics of quinapril and enalapril.
    Tarkiainen EK; Tornio A; Holmberg MT; Launiainen T; Neuvonen PJ; Backman JT; Niemi M
    Br J Clin Pharmacol; 2015 Nov; 80(5):1131-8. PubMed ID: 25919042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of carboxylesterase 1 genetic polymorphism on trandolapril activation in human liver and the pharmacokinetics and pharmacodynamics in healthy volunteers.
    Wang X; Her L; Xiao J; Shi J; Wu AH; Bleske BE; Zhu HJ
    Clin Transl Sci; 2021 Jul; 14(4):1380-1389. PubMed ID: 33660934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Pharmacokinetics of Enalapril in Relation to CES1 Genotype in Healthy Danish Volunteers.
    Stage C; Jürgens G; Guski LS; Thomsen R; Bjerre D; Ferrero-Miliani L; Lyauk YK; Rasmussen HB; Dalhoff K;
    Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):487-492. PubMed ID: 28639420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Influence of the
    Ikonnikova A; Rodina T; Dmitriev A; Melnikov E; Kazakov R; Nasedkina T
    J Pers Med; 2022 Apr; 12(4):. PubMed ID: 35455696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Influence of Structural Variants of the
    Ikonnikova A; Kazakov R; Rodina T; Dmitriev A; Melnikov E; Zasedatelev A; Nasedkina T
    Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetic study of CES1 gene and enalapril efficacy.
    Hussain M; Basheer S; Khalil A; Haider QUA; Saeed H; Faizan M
    J Appl Genet; 2024 Sep; 65(3):463-471. PubMed ID: 38261266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dabigatran etexilate activation is affected by the CES1 genetic polymorphism G143E (rs71647871) and gender.
    Shi J; Wang X; Nguyen JH; Bleske BE; Liang Y; Liu L; Zhu HJ
    Biochem Pharmacol; 2016 Nov; 119():76-84. PubMed ID: 27614009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphism on the single- and multiple-dose pharmacokinetics of enalapril in healthy Chinese adult men.
    Tian L; Liu H; Xie S; Jiang J; Han L; Huang Y; Li Y
    Clin Ther; 2011 May; 33(5):655-63. PubMed ID: 21665049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics profiles of enalapril maleate in healthy volunteers following determination of enalapril and enalaprilat by two specific enzyme immunoassays.
    Arafat T; Awad R; Hamad M; Azzam R; Al-Nasan A; Jehanli A; Matalka K
    J Clin Pharm Ther; 2005 Aug; 30(4):319-28. PubMed ID: 15985045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors.
    Wang X; Wang G; Shi J; Aa J; Comas R; Liang Y; Zhu HJ
    Pharmacogenomics J; 2016 Jun; 16(3):220-30. PubMed ID: 26076923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of CES1 genotypes on the pharmacokinetics of methylphenidate in healthy Danish subjects.
    Stage C; Jürgens G; Guski LS; Thomsen R; Bjerre D; Ferrero-Miliani L; Lyauk YK; Rasmussen HB; Dalhoff K;
    Br J Clin Pharmacol; 2017 Jul; 83(7):1506-1514. PubMed ID: 28087982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sacubitril Is Selectively Activated by Carboxylesterase 1 (CES1) in the Liver and the Activation Is Affected by CES1 Genetic Variation.
    Shi J; Wang X; Nguyen J; Wu AH; Bleske BE; Zhu HJ
    Drug Metab Dispos; 2016 Apr; 44(4):554-9. PubMed ID: 26817948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically-Based Pharmacokinetic Modeling to Predict Methylphenidate Exposure Affected by Interplay Among Carboxylesterase 1 Pharmacogenetics, Drug-Drug Interactions, and Sex.
    Xiao J; Shi J; Thompson BR; Smith DE; Zhang T; Zhu HJ
    J Pharm Sci; 2022 Sep; 111(9):2606-2613. PubMed ID: 35526575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans.
    Oh J; Lee S; Lee H; Cho JY; Yoon SH; Jang IJ; Yu KS; Lim KS
    PLoS One; 2017; 12(4):e0176320. PubMed ID: 28437488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators.
    Her L; Zhu HJ
    Drug Metab Dispos; 2020 Mar; 48(3):230-244. PubMed ID: 31871135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of carboxylesterase 1 polymorphism and cannabidiol on the hepatic metabolism of heroin.
    Qian Y; Gilliland TK; Markowitz JS
    Chem Biol Interact; 2020 Jan; 316():108914. PubMed ID: 31837295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of enalapril and enalaprilat by enzyme linked immunosorbent assays: application to pharmacokinetic and pharmacodynamic analysis.
    Matalka K; Arafat T; Hamad M; Jehanli A
    Fundam Clin Pharmacol; 2002 Jun; 16(3):237-44. PubMed ID: 12165071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of a nitric oxide-releasing derivative of enalapril in male beagles.
    Okuyama CE; Mendes GD; Faro R; Rezende VM; Lagos RM; Astigarraga RE; Antunes E; De Nucci G
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):290-5. PubMed ID: 17324140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxylesterase 1 c.428G>A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humans.
    Tarkiainen EK; Holmberg MT; Tornio A; Neuvonen M; Neuvonen PJ; Backman JT; Niemi M
    Clin Pharmacol Ther; 2015 Jun; 97(6):650-8. PubMed ID: 25704243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.